Olema Pharmaceuticals, Inc. (OLMA) › Shareholders' EquityOlema Pharmaceuticals, Inc. (OLMA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$8.40M2019: -$10.59M2020: $338.14M2021: $284.57M2022: $197.55M2023: $253.90M2024: $408.96M2025: $478.56M$478.56M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$478.56M+17.0%2024$408.96M+61.1%2023$253.90M+28.5%2022$197.55M-30.6%2021$284.57M-15.8%2020$338.14M+3291.8%2019-$10.59M-26.2%2018-$8.40M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share